Short communication · 29 Dec 2025
Conference abstractPublished 19 Apr 2018
Impact of a moderate-fat meal on the bioavailability of Ribavirin in patients with hepatitis C
King Abdulaziz Medical City, Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ribavirin is a nucleoside analog used in hepatitis C therapy. The bioavailability of oral Ribavirin is increased by coadministration with high-fat food. Therefore, Ribavirin manufacturers recommend taking the drug with food. However, moderate fat meal effect on Ribavirin bioavailability is yet not established. Our objectives were to compare the bioavailability of Ribavirin in patients with hepatitis C virus (HCV) genotype 4 (G4), either taken after a moderate-fat meal or in fasting state. We conducted a crossover, randomized, open-label study including 82 naÃ?¯ve patients (49 women and 33 men, mean age 53.40Ã?±1.39 years) with chronic hepatitis C at King Abdulaziz Medical City, Riyadh, Saudi Arabia, from 2012 to 2014. Patients received 600 mg of oral Ribavirin on two occasions at least three weeks apart of washout period: first in a fasting state and second time after a moderate fat breakfast containing X18 g fat. Participants in both states underwent a pharmacokinetic profile analysis at 0.5, 1.0 and 2.0 hours after each dose. Compared with the fed state, Ribavirin plasma concentrations were significantly higher in the fasting state at 0.5 hours and 1 hour post-dose (p=0.004 and 0.021, respectively) and significantly lower at 2 hours post-dose (p=0.011). However, the area under the curve for Ribavirin concentrations within the first 4 hours post-dose (AUC0-4h) was not different between the two states (p=0.956). Among adult patients with HCV G4, there was no significant difference in Ribavirin bioavailability between fasting and fed (X18 gram fat meal) states, thus for better adherence we recommend that physicians consider patient convenience in regards to the timing of Ribavirin oral intake.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Molecular and Genetic Medicine.
Brief report · 29 Dec 2025
Multi-Omics: Accelerating Biomarker Discovery and Disease Insights
Short communication · 29 Dec 2025
RNA Editing: a Role in Health and Disease
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular and Genetic Medicine
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Sara Ibrahim Altraif”
- BylineArticles whose byline prints “Shazia Murtaza”
- BylineArticles whose byline prints “Pierre Marquet”
- BylineArticles whose byline prints “Abdulkareem Albekairy”
- BylineArticles whose byline prints “Faisal M Sanai”
- BylineArticles whose byline prints “Hamdan Alghamdi”
- BylineArticles whose byline prints “Abduljaleel Alalwan”
- BylineArticles whose byline prints “Abdulrahman Aljumah”
